Gohi Bi Foua Claude Alain, Liu Xue-Ying, Zeng Hong-Yan, Xu Sheng, Ake Kouassi Marius Honore, Cao Xiao-Ju, Zou Kai-Min, Namulondo Sheila
1Biology and Chemical Engineering School, Panzhihua University, Panzhihua, 617000 Sichuan People's Republic of China.
2Biotechnology Institute, College of Chemical Engineering, Xiangtan University, Xiangtan, 411105 Hunan People's Republic of China.
Cell Biosci. 2020 Jan 6;10:2. doi: 10.1186/s13578-019-0367-y. eCollection 2020.
A two-stage method of obtaining viable human amniotic stem cells (hAMSCs) in large-scale is described. First, human amniotic stem cells are isolated via dual enzyme (collagenase II and DNAase I) digestion. Next, relying on a culture of the cells from porous chitosan-based microspheres in vitro, high purity hAMSCs are obtained in large-scale. Dual enzymatic (collagenase II and DNase I) digestion provides a primary cell culture and first subculture with a lower contamination rate, higher purity and a larger number of isolated cells. The obtained hAMSCs were seeded onto chitosan microspheres (CM), gelatin-chitosan microspheres (GCM) and collagen-chitosan microspheres (CCM) to produce large numbers of hAMSCs for clinical trials. Growth activity measurement and differentiation essays of hAMSCs were realized. Within 2 weeks of culturing, GCMs achieved over 1.28 ± 0.06 × 10 hAMSCs whereas CCMs and CMs achieved 7.86 ± 0.11 × 10 and 1.98 ± 0.86 × 10 respectively within this time. In conclusion, hAMSCs showed excellent attachment and viability on GCM-chitosan microspheres, matching the hAMSCs' normal culture medium. Therefore, dual enzyme (collagenase II and DNAase I) digestion may be a more useful isolation process and culture of hAMSCs on porous GCM in vitro as an ideal environment for the large-scale expansion of highly functional hAMSCs for eventual use in stem cell-based therapy.
本文描述了一种分两阶段大规模获取 viable 人羊膜干细胞(hAMSCs)的方法。首先,通过双酶(胶原酶 II 和脱氧核糖核酸酶 I)消化分离人羊膜干细胞。接下来,依靠体外基于多孔壳聚糖的微球对细胞进行培养,大规模获得高纯度的 hAMSCs。双酶(胶原酶 II 和脱氧核糖核酸酶 I)消化为原代细胞培养和首次传代培养提供了较低的污染率、较高的纯度以及更多数量的分离细胞。将获得的 hAMSCs 接种到壳聚糖微球(CM)、明胶 - 壳聚糖微球(GCM)和胶原 - 壳聚糖微球(CCM)上,以生产大量用于临床试验的 hAMSCs。实现了 hAMSCs 的生长活性测量和分化试验。在培养的 2 周内,GCMs 获得了超过 1.28±0.06×10 的 hAMSCs,而在此期间 CCMs 和 CMs 分别获得了 7.86±0.11×10 和 1.98±0.86×10。总之,hAMSCs 在 GCM - 壳聚糖微球上显示出优异的附着性和活力,与 hAMSCs 的正常培养基相当。因此,双酶(胶原酶 II 和脱氧核糖核酸酶 I)消化可能是一种更有用的分离过程,并且在体外多孔 GCM 上培养 hAMSCs 作为大规模扩增高功能 hAMSCs 最终用于干细胞治疗的理想环境。 (注:原文中“viable”翻译为“有活力的、能存活的”,这里直接保留英文未翻译完整,可能原文表述有误,正常应完整翻译)